ES2183923T3 - Derivados de cromona. - Google Patents

Derivados de cromona.

Info

Publication number
ES2183923T3
ES2183923T3 ES96810237T ES96810237T ES2183923T3 ES 2183923 T3 ES2183923 T3 ES 2183923T3 ES 96810237 T ES96810237 T ES 96810237T ES 96810237 T ES96810237 T ES 96810237T ES 2183923 T3 ES2183923 T3 ES 2183923T3
Authority
ES
Spain
Prior art keywords
chromone derivatives
chromone
derivatives
antagonists
rings
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96810237T
Other languages
English (en)
Inventor
Sprecher Andreas Dr Von
Marc Dr Gerspacher
Robert Dr Mah
Walter Dr Schilling
Silvio Dr Ofner
Siem Jacob Dr Veenstra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2183923T3 publication Critical patent/ES2183923T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

COMPUESTOS DE FORMULA I, DEFINIENDO LOS ANILLOS A Y B EN LA DESCRIPCION, POSEEN VALIOSAS PROPIEDADES FARMACEUTICAS, Y SON EFECTIVOS COMO ANTAGONISTAS DE LA NK1 O DE LA SUSTANCIA P.SE OBTIENEN DE FORMA CONOCIDA.
ES96810237T 1995-04-24 1996-04-16 Derivados de cromona. Expired - Lifetime ES2183923T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH115795 1995-04-24

Publications (1)

Publication Number Publication Date
ES2183923T3 true ES2183923T3 (es) 2003-04-01

Family

ID=4203819

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96810237T Expired - Lifetime ES2183923T3 (es) 1995-04-24 1996-04-16 Derivados de cromona.

Country Status (21)

Country Link
US (1) US5604247A (es)
EP (1) EP0739892B1 (es)
JP (1) JP3068458B2 (es)
KR (1) KR100416674B1 (es)
CN (1) CN1063176C (es)
AR (1) AR001813A1 (es)
AT (1) ATE224891T1 (es)
AU (1) AU714523B2 (es)
BR (1) BR9602025A (es)
CA (1) CA2174707C (es)
DE (1) DE59609707D1 (es)
DK (1) DK0739892T3 (es)
ES (1) ES2183923T3 (es)
HU (1) HUP9601062A3 (es)
IL (1) IL117989A (es)
NO (1) NO309813B1 (es)
NZ (1) NZ286422A (es)
PT (1) PT739892E (es)
RU (1) RU2156250C2 (es)
TW (1) TW475930B (es)
ZA (1) ZA963211B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2255910A1 (en) * 1996-05-24 1997-11-27 Mitchell Irvin Steinberg Methods of treating hypertension
TW426667B (en) * 1997-11-19 2001-03-21 Pfizer Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
CN1216598C (zh) * 1998-08-25 2005-08-31 诺瓦提斯公司 药物用途
WO2000071538A2 (en) * 1999-05-21 2000-11-30 Pfizer Products Inc. 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
GB0220953D0 (en) 2002-09-10 2002-10-23 Novartis Ag Organic compounds
GB2394417A (en) * 2002-10-24 2004-04-28 Novartis Ag Solid dispersion comprising a piperidine substance P antagonist and a carrier
DE10256182A1 (de) * 2002-12-02 2004-06-24 Merck Patent Gmbh 2-Oxadiazolchromonderivate
DE10256174A1 (de) * 2002-12-02 2004-06-09 Merck Patent Gmbh 2-Benzoylchromonderivate
US20050209274A1 (en) * 2004-02-26 2005-09-22 Lynch John K Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
CN1300163C (zh) * 2004-06-23 2007-02-14 南京大学 3－羟基色原酮糖苷及其制法和用途
MY144307A (en) * 2006-04-18 2011-08-29 Abbott Lab Antagonists of the vanilloid receptor subtype 1 (vr1) and uses thereof
GB0701365D0 (en) * 2007-01-24 2007-03-07 Glaxo Group Ltd Novel pharmaceutical compositions
UA105182C2 (ru) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3117389A1 (de) * 1981-05-02 1982-11-18 Boehringer Mannheim Gmbh, 6800 Mannheim Benzopyranylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
MY110227A (en) * 1991-08-12 1998-03-31 Ciba Geigy Ag 1-acylpiperindine compounds.
AU7856194A (en) * 1993-10-26 1995-05-22 Ciba-Geigy Ag N-benzoyl-4-oxy/thio-2-substituted piperidines as substance-p receptor antagonists
US5935951A (en) * 1994-09-30 1999-08-10 Novartis Finance Corporation 1-acyl-4-aliphatylaminopiperidine compounds
TW397825B (en) * 1994-10-14 2000-07-11 Novartis Ag Aroyl-piperidine derivatives

Also Published As

Publication number Publication date
JPH093066A (ja) 1997-01-07
HUP9601062A2 (en) 1997-10-28
EP0739892A3 (de) 1997-01-22
AU5080596A (en) 1996-11-07
HU9601062D0 (en) 1996-06-28
CA2174707A1 (en) 1996-10-25
RU2156250C2 (ru) 2000-09-20
NO309813B1 (no) 2001-04-02
KR960037680A (ko) 1996-11-19
EP0739892A2 (de) 1996-10-30
MX9601515A (es) 1997-09-30
US5604247A (en) 1997-02-18
NO961616L (no) 1996-10-25
AU714523B2 (en) 2000-01-06
TW475930B (en) 2002-02-11
NO961616D0 (no) 1996-04-23
CN1141921A (zh) 1997-02-05
DK0739892T3 (da) 2003-01-20
ATE224891T1 (de) 2002-10-15
ZA963211B (en) 1996-10-24
IL117989A0 (en) 1996-08-04
JP3068458B2 (ja) 2000-07-24
CA2174707C (en) 2008-03-25
CN1063176C (zh) 2001-03-14
DE59609707D1 (de) 2002-10-31
NZ286422A (en) 1998-01-26
IL117989A (en) 2000-01-31
PT739892E (pt) 2003-01-31
EP0739892B1 (de) 2002-09-25
HUP9601062A3 (en) 1998-10-28
AR001813A1 (es) 1997-12-10
KR100416674B1 (ko) 2004-06-11
BR9602025A (pt) 1998-10-06

Similar Documents

Publication Publication Date Title
EA199700118A1 (ru) Трициклические диазепины в качестве антагонистов вазопрессина, способ их получения и способ лечения с использованием трициклических диазепинов
PT942904E (pt) Derivados de 3-tiocarbamoilpirazol como pesticidas
DE59709414D1 (de) Oxyiminopregnancarbolactone
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
DE69636791D1 (de) Derivate von glykopeptidantibiotika
DE59610557D1 (de) Heterozyklisch substituierte biphenylamid derivate, deren herstellung und deren verwendung als fungizide
ES2158327T3 (es) Derivados de benzo(g)quinolina.
ES2193137T3 (es) Heteroaril aminas como nuevos inhibidors de acetilcolinesterasa.
DE69716925D1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
ES2183923T3 (es) Derivados de cromona.
BR9711586A (pt) Compostos e uso dos mesmo
AR016981A2 (es) Polipeptidos sinteticos
TR199900363T2 (xx) NK1 ve NK2 antagonistleri olarak asilaminoalkenilen-amid t�revleri.
AR008781A1 (es) Compuestos de furano nitrona
MX210235B (es) Oxiranil-triazolintionas y su empleo como microbicidas
ES2032317T3 (es) Derivados de quinazolina tetraciclicos, obtencion y empleo.
TR200000637T2 (tr) Benzoksazin ve benzotiazin türevleri ve bunların ilaçlarda kullanımı.
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri
TR199801485T2 (xx) Yeni 2,3 benzodiyazepin t�revleri, bu t�revlerin �retimi ve ila� olarak kullan�m�.
AR005704A1 (es) Heteroariloxazolidinonas
ATE217619T1 (de) Endothelin-rezeptor-antagonisten
DE69527630T2 (de) Wasserlösliche glykolisierte derivate von 1,2-dithiinverbindungen
ES2073919T3 (es) Derivados de piperidina 1,3,4-trisubstituidos, su obtencion y empleo.
ATE202101T1 (de) Sulfonylbenzazolone
ECSP972175A (es) DERIVADOS DE BENZO (g) QUINOLINA